Hematopoietic Progenitor Kinase1 (HPK1) Mediates T Cell Dysfunction and Is a Druggable Target for T Cell-Based Immunotherapies.
暂无分享，去创建一个
D. Dimitrov | Yan Gao | B. Pang | D. An | Lai Wei | J. Min | Ligong Chen | B. Zou | G. Gao | Xing Liu | Yan Sun | Yaopeng Li | Wenna Chi | Jingwen Si | Xuebin Liao | Tian Liu | Xingyu Lin | Wen Yin | Xiangjun Shi | Xinru Du | Shu-Qing Sun | Fei Long | Shuhao Sun | Bin Zou